Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Sarah Dumont
Docetaxel, Cisplatin, and 5-Fluorouracil (DCF) Chemotherapy in the Treatment of Metastatic or Unresectable Locally Recurrent Anal Squamous Cell Carcinoma: A Phase II Study of French Interdisciplinary GERCOR and FFCD Groups (Epitopes-Hpv02 Study)
BMC Cancer
Cancer Research
Oncology
Genetics
Related publications
Phase II Study of Docetaxel and Irinotecan Combination Chemotherapy in Metastatic Gastric Carcinoma
British Journal of Cancer
Cancer Research
Oncology
A Phase II Evaluation of a 3-Hour Infusion of Paclitaxel, Cisplatin, and 5-Fluorouracil in Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck
Cancer
Cancer Research
Oncology
Weekly Chemotherapy of 5‐Fluorouracil Plus Cisplatin Concurrent With Radiotherapy for Esophageal Squamous Cell Carcinoma Patients With Postoperative Locoregional Recurrence: Results From a Phase II Study
Oncologist
Cancer Research
Medicine
Oncology
Induction With Mitomycin C, Doxorubicin, Cisplatin and Maintenance With Weekly 5-Fluorouracil, Leucovorin for Treatment of Metastatic Nasopharyngeal Carcinoma: A Phase II Study
British Journal of Cancer
Cancer Research
Oncology
Cisplatin/Tegafur/Uracil/Irinotecan Triple Combination Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma: A Phase I/Ii Clinical Study
Oncologist
Cancer Research
Medicine
Oncology
A Phase II Study of Temsirolimus and Erlotinib in Patients With Recurrent and/or Metastatic, Platinum-Refractory Head and Neck Squamous Cell Carcinoma
Oral Oncology
Cancer Research
Oral Surgery
Oncology
Adoptive T-Cell Transfer and Chemotherapy in the First-Line Treatment of Metastatic and/or Locally Recurrent Nasopharyngeal Carcinoma
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
A Phase II Study of Axalimogene Filolisbac for Patients With Previously Treated, Unresectable, Persistent/Recurrent Loco-Regional or Metastatic Anal Cancer
Oncotarget
Oncology
SWOG 0514: A Phase II Study of Sorafenib in Patients With Unresectable or Metastatic Gallbladder Carcinoma and Cholangiocarcinoma
Investigational New Drugs
Oncology
Pharmacology
